Silence Therapeutics PLC (SLN)
13.98
-1.30
(-8.54%)
USD |
NASDAQ |
Nov 14, 16:00
13.98
0.00 (0.00%)
After-Hours: 18:09
Silence Therapeutics Market Cap: 654.00M for Nov. 14, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2024 | 715.07M |
| November 12, 2024 | 758.59M |
| November 11, 2024 | 820.83M |
| November 08, 2024 | 819.90M |
| November 07, 2024 | 833.94M |
| November 06, 2024 | 841.89M |
| November 05, 2024 | 824.58M |
| November 04, 2024 | 834.40M |
| November 01, 2024 | 827.39M |
| October 31, 2024 | 809.60M |
| October 30, 2024 | 811.47M |
| October 29, 2024 | 842.36M |
| October 28, 2024 | 845.64M |
| October 25, 2024 | 846.10M |
| October 24, 2024 | 840.96M |
| October 23, 2024 | 843.30M |
| October 22, 2024 | 842.36M |
| October 21, 2024 | 840.96M |
| October 18, 2024 | 841.89M |
| October 17, 2024 | 865.76M |
| October 16, 2024 | 866.70M |
| October 15, 2024 | 855.93M |
| October 14, 2024 | 878.86M |
| October 11, 2024 | 919.58M |
| October 10, 2024 | 898.52M |
| Date | Value |
|---|---|
| October 09, 2024 | 903.20M |
| October 08, 2024 | 910.22M |
| October 07, 2024 | 870.91M |
| October 04, 2024 | 872.31M |
| October 03, 2024 | 901.79M |
| October 02, 2024 | 861.08M |
| October 01, 2024 | 853.12M |
| September 30, 2024 | 850.78M |
| September 27, 2024 | 854.06M |
| September 26, 2024 | 815.69M |
| September 25, 2024 | 845.64M |
| September 24, 2024 | 853.59M |
| September 23, 2024 | 842.36M |
| September 20, 2024 | 855.00M |
| September 19, 2024 | 856.87M |
| September 18, 2024 | 854.53M |
| September 17, 2024 | 853.12M |
| September 16, 2024 | 853.12M |
| September 13, 2024 | 874.65M |
| September 12, 2024 | 869.50M |
| September 11, 2024 | 868.57M |
| September 10, 2024 | 879.80M |
| September 09, 2024 | 886.35M |
| September 06, 2024 | 872.78M |
| September 05, 2024 | 882.14M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
166.04M
Minimum
Apr 24 2023
1.221B
Maximum
Mar 04 2024
593.16M
Average
629.93M
Median
Dec 22 2023
Market Cap Benchmarks
| NuCana PLC | 3.493M |
| TC BioPharm (Holdings) PLC | 0.3214M |
| Biodexa Pharmaceuticals PLC | 2.799M |
| Adaptimmune Therapeutics PLC | 150.89M |
| Verona Pharma PLC | 2.893B |
Market Cap Related Metrics
| PS Ratio | 25.76 |
| Price to Book Value | 4.596 |
| Price | 13.98 |
| Earnings Yield | -8.73% |